177 related articles for article (PubMed ID: 8760292)
41. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
Lee HC; Wang H; Baladandayuthapani V; Lin H; He J; Jones RJ; Kuiatse I; Gu D; Wang Z; Ma W; Lim J; O'Brien S; Keats J; Yang J; Davis RE; Orlowski RZ
Br J Haematol; 2017 Apr; 177(1):80-94. PubMed ID: 28369725
[TBL] [Abstract][Full Text] [Related]
42. [Expression of pituitary tumor transforming gene and C-myc gene in patients with multiple myeloma].
Li DQ; Chen P; Shao JH; Dong XB; Chang YL; Zhao HY; Zhou YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1238-41. PubMed ID: 19840458
[TBL] [Abstract][Full Text] [Related]
43. Post-transcriptional deregulation of myc genes in lung cancer cell lines.
Bernasconi NL; Wormhoudt TA; Laird-Offringa IA
Am J Respir Cell Mol Biol; 2000 Oct; 23(4):560-5. PubMed ID: 11017923
[TBL] [Abstract][Full Text] [Related]
44. IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.
Shi Y; Frost PJ; Hoang BQ; Benavides A; Sharma S; Gera JF; Lichtenstein AK
Cancer Res; 2008 Dec; 68(24):10215-22. PubMed ID: 19074889
[TBL] [Abstract][Full Text] [Related]
45. Translation of c-myc mRNA is required for its post-transcriptional regulation during myogenesis.
Wisdom R; Lee W
J Biol Chem; 1990 Nov; 265(31):19015-21. PubMed ID: 2229059
[TBL] [Abstract][Full Text] [Related]
46. Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiation.
Greil R; Loidl P; Fasching B; Huber H
Curr Top Microbiol Immunol; 1992; 182():215-21. PubMed ID: 1490357
[No Abstract] [Full Text] [Related]
47. The polyadenylation inhibitor cordycepin (3'dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levels.
Ioannidis P; Courtis N; Havredaki M; Michailakis E; Tsiapalis CM; Trangas T
Oncogene; 1999 Jan; 18(1):117-25. PubMed ID: 9926926
[TBL] [Abstract][Full Text] [Related]
48. Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.
Shi Y; Sun F; Cheng Y; Holmes B; Dhakal B; Gera JF; Janz S; Lichtenstein A
Mol Cancer Ther; 2022 Apr; 21(4):502-510. PubMed ID: 35086951
[TBL] [Abstract][Full Text] [Related]
49. Systematic analysis of the contribution of c-myc mRNA constituents upon cap and IRES mediated translation.
Meristoudis C; Trangas T; Lambrianidou A; Papadopoulos V; Dimitriadis E; Courtis N; Ioannidis P
Biol Chem; 2015 Dec; 396(12):1301-13. PubMed ID: 26351916
[TBL] [Abstract][Full Text] [Related]
50. Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.
Jernberg-Wiklund H; Pettersson M; Larsson LG; Anton R; Nilsson K
Int J Cancer; 1992 Apr; 51(1):116-23. PubMed ID: 1563831
[TBL] [Abstract][Full Text] [Related]
51. Effect of temperature on protein and immunoglobulin synthesis and secretion in two mouse myeloma cell lines.
Craig N
J Cell Physiol; 1979 Aug; 100(2):323-34. PubMed ID: 511946
[TBL] [Abstract][Full Text] [Related]
52. cis-acting determinants of c-myc mRNA stability.
Cole MD; Mango SE
Enzyme; 1990; 44(1-4):167-80. PubMed ID: 2133648
[TBL] [Abstract][Full Text] [Related]
53. Targeting of c-myc and beta-globin coding sequences to cytoskeletal-bound polysomes by c-myc 3' untranslated region.
Hesketh J; Campbell G; Piechaczyk M; Blanchard JM
Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):143-8. PubMed ID: 8129712
[TBL] [Abstract][Full Text] [Related]
54. Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation.
Pistoi S; Roland J; Babinet C; Morello D
Mol Cell Biol; 1996 Sep; 16(9):5107-16. PubMed ID: 8756668
[TBL] [Abstract][Full Text] [Related]
55. Addiction to c-MYC in multiple myeloma.
Holien T; Våtsveen TK; Hella H; Waage A; Sundan A
Blood; 2012 Sep; 120(12):2450-3. PubMed ID: 22806891
[TBL] [Abstract][Full Text] [Related]
56. Characterization of c-myc 3' to 5' mRNA decay activities in an in vitro system.
Brewer G
J Biol Chem; 1998 Dec; 273(52):34770-4. PubMed ID: 9857001
[TBL] [Abstract][Full Text] [Related]
57. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA.
Prokipcak RD; Herrick DJ; Ross J
J Biol Chem; 1994 Mar; 269(12):9261-9. PubMed ID: 8132663
[TBL] [Abstract][Full Text] [Related]
58. A localisation signal in the 3' untranslated region of c-myc mRNA targets c-myc mRNA and beta-globin reporter sequences to the perinuclear cytoplasm and cytoskeletal-bound polysomes.
Veyrune JL; Campbell GP; Wiseman J; Blanchard JM; Hesketh JE
J Cell Sci; 1996 Jun; 109 ( Pt 6)():1185-94. PubMed ID: 8799809
[TBL] [Abstract][Full Text] [Related]
59. Polysome trafficking of transcripts and microRNAs in regenerating liver after partial hepatectomy.
Kren BT; Wong PY; Shiota A; Zhang X; Zeng Y; Steer CJ
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1181-92. PubMed ID: 19779017
[TBL] [Abstract][Full Text] [Related]
60. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.
Weinhold N; Meissner T; Johnson DC; Seckinger A; Moreaux J; Försti A; Chen B; Nickel J; Chubb D; Rawstron AC; Doughty C; Dahir NB; Begum DB; Young K; Walker BA; Hoffmann P; Nöthen MM; Davies FE; Klein B; Goldschmidt H; Morgan GJ; Houlston RS; Hose D; Hemminki K
Haematologica; 2015 Mar; 100(3):e110-3. PubMed ID: 25480495
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
